Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
240
-
Total 13F shares, excl. options
-
63.9M
-
Shares change
-
-655K
-
Total reported value, excl. options
-
$2.11B
-
Value change
-
-$13.3M
-
Put/Call ratio
-
0
-
Number of buys
-
136
-
Number of sells
-
-106
-
Price
-
$33.15
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2017
277 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2017.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 240 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.9M shares
of 115M outstanding shares and own 55.46% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.45M shares), VANGUARD GROUP INC (5.71M shares), WELLINGTON MANAGEMENT GROUP LLP (5.33M shares), Consonance Capital Management LP (2.84M shares), JANUS HENDERSON GROUP PLC (2.68M shares), Bank of New York Mellon Corp (2.62M shares), STATE STREET CORP (2.38M shares), Van Berkom & Associates Inc. (1.98M shares), ABERDEEN ASSET MANAGEMENT PLC/UK (1.81M shares), and DIMENSIONAL FUND ADVISORS LP (1.81M shares).
This table shows the top 240 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.